Retinal optogenetic therapies: clinical criteria for candidacy.
about
Optogenetic approaches to retinal prosthesisTherapeutic potential of optogenetic neuromodulationPupillary Light Reflexes in Severe Photoreceptor Blindness Isolate the Melanopic Component of Intrinsically Photosensitive Retinal Ganglion Cells.Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: determining the timing and expectation of therapy.Improvement in vision: a new goal for treatment of hereditary retinal degenerationsHalting progressive neurodegeneration in advanced retinitis pigmentosaLet There Be Light: Gene and Cell Therapy for Blindness.Advances in Gene Therapy for Diseases of the Eye.Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina.Postretinal Structure and Function in Severe Congenital Photoreceptor Blindness Caused by Mutations in the GUCY2D Gene.Inner and outer retinal changes in retinal degenerations associated with ABCA4 mutations.Aberrant protein trafficking in retinal degenerations: The initial phase of retinal remodeling.Shining Light on the Sprout of Life: Optogenetics Applications in Stem Cell Research and Therapy.A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina.Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy.Comparison of 5-year progression of retinitis pigmentosa involving the posterior pole among siblings by means of SD-OCT: a retrospective study.Cochlear Gene Therapy for Sensorineural Hearing Loss: Current Status and Major Remaining Hurdles for Translational Success.
P2860
Q27009269-21AFDBFC-7230-48FD-B7E3-AD087084D1EBQ28084334-6EB34E1B-ED1B-4D99-AD8B-4FA7A96E7C62Q32186770-03B0BD3F-9264-4C01-92CA-DD36532C8783Q35132187-4F822EE5-3C41-42BD-AB43-7C741B937B5CQ35805426-D2AE1240-B284-4706-88E5-3FAF6D30FBD3Q36106057-FB2F11D4-2DB9-48A2-9CED-40DDEF284E0AQ36654534-57FEFD55-4B03-4FA2-BC6A-F8C418B57760Q37190609-5D785D71-9513-43B5-869F-C45968D98A6BQ37386985-FE0D37D2-3E25-405C-9601-7B58736932CCQ37641855-B501B0F1-9888-459E-AE92-83D481352D3DQ37671070-3FCC692B-FF4E-4A49-A368-DA640E9BCF68Q38657660-736EFCB7-A047-4BDA-AAAC-66FC2B525C51Q38752231-8B1385A9-E4DF-4550-B2A4-352600375795Q38936694-40E1418F-2D96-4B84-8800-B90F518533F9Q41925316-2D564F3F-B5E4-444F-9262-C3AB88C02736Q55512502-14ECCDFA-6B99-4C4B-9F35-6CF09721F7BAQ55657184-C1D1AA0E-8D2C-4247-B9AA-151435254F30
P2860
Retinal optogenetic therapies: clinical criteria for candidacy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Retinal optogenetic therapies: clinical criteria for candidacy.
@en
Retinal optogenetic therapies: clinical criteria for candidacy.
@nl
type
label
Retinal optogenetic therapies: clinical criteria for candidacy.
@en
Retinal optogenetic therapies: clinical criteria for candidacy.
@nl
prefLabel
Retinal optogenetic therapies: clinical criteria for candidacy.
@en
Retinal optogenetic therapies: clinical criteria for candidacy.
@nl
P2093
P2860
P356
P1433
P1476
Retinal optogenetic therapies: clinical criteria for candidacy.
@en
P2093
P2860
P304
P356
10.1111/CGE.12165
P577
2013-05-13T00:00:00Z